Microbiotix Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Microbiotix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013979
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Microbiotix Inc (Microbiotix) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of infectious diseases. The company provides products for hepatitis C virus and human cytomegalovirus including HCV NS5B MBX-700, MBX-701 and MBX-400. It also provides antibacterial and antiviral discovery programs on filoviruses, malarial, gram-negative bacterial infections, tuberculosis and influenza. Microbiotix RNA-dependent RNA polymerase is HCV NS5B, used for the replication of the viral genome. The company offers products for the treatment of hepatitis c and human cytomegalovirus infection of neonates. Microbiotix is headquartered in Worcester, Massachusetts, the US.

Microbiotix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Microbiotix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Microbiotix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Microbiotix Enters into Co-Development Agreement with AMR Centre 10
Licensing Agreements 11
Microbiotix Receives Notice for Exclusive Patent License from National Institutes of Health 11
Microbiotix Enters Into Licensing Agreement With Merck For MBX-700 And MBX-701 12
Microbiotix Inc – Key Competitors 13
Microbiotix Inc – Key Employees 14
Microbiotix Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Microbiotix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Microbiotix Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Microbiotix Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Microbiotix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Microbiotix Enters into Co-Development Agreement with AMR Centre 10
Microbiotix Receives Notice for Exclusive Patent License from National Institutes of Health 11
Microbiotix Enters Into Licensing Agreement With Merck For MBX-700 And MBX-701 12
Microbiotix Inc, Key Competitors 13
Microbiotix Inc, Key Employees 14

★海外企業調査レポート[Microbiotix Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maquet Holding BV & Co KG:企業の戦略的SWOT分析
    Maquet Holding BV & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring …
  • Syngenta AG:企業の戦略的SWOT分析
    Syngenta AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Rubicon Research Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Research Pvt Ltd (Rubicon), a subsidiary of Everstone Capital Management, is a drug delivery technology company that develops, manufactures and markets next-generation pharmaceutical products. The company’s products include central nervous system, cardiovascular, cough, cold and anti …
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Green Cross Cell Corp (031390):製薬・医療:M&Aディール及び事業提携情報
    Summary Green Cross Cell Corp (Green Cross Cell), a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offers cryopreservation of co …
  • Lucasfilm Ltd:企業の戦略的SWOT分析
    Lucasfilm Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Fonterra Co-operative Group Ltd:戦略・SWOT・企業財務分析
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. APL also offers branded formulations in the areas of antibiotics and anti …
  • Lietuvos energijos gamyba, AB (LNR1L)-エネルギー分野:企業M&A・提携分析
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Interventional Spine, Inc.-医療機器分野:企業M&A・提携分析
    Summary Interventional Spine, Inc. (Interventional Spine) is a medical device company, which designs, develops and markets patented systems to treat back pain. The company’s major products include PerX360° percutaneous lumbar fusion system, PERPOS PLS percutaneous transfacet-pedicular compression sy …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • Gulfsands Petroleum Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfsands Petroleum Plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Ecolab Inc.:企業の戦略・SWOT・財務分析
    Ecolab Inc. - Strategy, SWOT and Corporate Finance Report Summary Ecolab Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Consejo Superior de Investigaciones Cientificas-製薬・医療分野:企業M&A・提携分析
    Summary Consejo Superior de Investigaciones Cientificas (CSIC) is a research institute that provides research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management …
  • Sophia Genetics SA:医療機器:M&Aディール及び事業提携情報
    Summary Sophia Genetics SA (Sophia Genetics) is a health tech company that provides technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solution, and integrated diagnostic s …
  • Vinci Construction UK Ltd:企業の戦略・SWOT・財務情報
    Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Vinci Construction UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Malaysian Pacific Industries Berhad (MPI):企業の財務・戦略的SWOT分析
    Malaysian Pacific Industries Berhad (MPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆